Clinical Trial Update: Neoadjuvant Adebrelimab Plus Chemotherapy for Esophageal Cancer: A Clinical Study [Phase 2]

View source ↗

Summary

This update notes an ongoing Phase 2 clinical trial evaluating neoadjuvant adebrelimab combined with chemotherapy for esophageal squamous cell carcinoma, curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)

Snippet

Sponsor: The Affiliated Hospital of Putian University | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING